Stryker Says OptaBlate Receives FDA Clearance for Low Back Pain Relief-February 2024-www.financetom.com

Stryker Says OptaBlate Receives FDA Clearance for Low Back Pain Relief

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Stryker Says OptaBlate Receives FDA Clearance for Low Back Pain Relief

May 26, 2025 10:22 AM

01:24 PM EDT, 05/19/2025 (MT Newswires) -- Stryker (SYK) said Monday its OptaBlate basivertebral nerve ablation system received 510(k) clearance from the US Food and Drug Administration.

OptaBlate is used in a minimally invasive procedure to provide relief from vertebrogenic low back pain, the company said.

Stryker said the system, which expands its advanced pain therapy portfolio, combines its competencies in radiofrequency ablation and vertebral access.

Price: 393.34, Change: -0.88, Percent Change: -0.22

Previous page： Morgan Stanley lowers climate target, warns on sluggish transition Next page： Colgate-Palmolive Beats Q3 Earnings Amid Market Share Gains And Margin Expansion, Raises 2024 Outlook

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Morgan Stanley lowers climate target, warns on sluggish transition

Oct 26, 2024

LONDON (Reuters) - Morgan Stanley ( MS ) has lowered its expectations for cutting emissions from its corporate lending portfolio as the world is moving too slowly to a greener economy, the bank's chief sustainability officer told Reuters. A slowdown in electric vehicle sales, lagging adoption of biofuels in aviation and funding and policy hurdles in the power sector were...

Colgate-Palmolive Beats Q3 Earnings Amid Market Share Gains And Margin Expansion, Raises 2024 Outlook

Oct 26, 2024

Colgate-Palmolive Company ( CL ) reported third-quarter adjusted earnings per share of 91 cents, beating the street view of 89 cents. Quarterly sales of $5.033 billion (+2.4%) beat the street view of $5.003 billion, driven by a “healthy” balance of volume growth and higher pricing. Colgate said in a press release that for the sixth consecutive quarter, the company has...

Rakovina Therapeutics Presents Research on Small-Molecule Bifunctional Inhibitors

Oct 26, 2024

08:08 AM EDT, 10/25/2024 (MT Newswires) -- Rakovina Therapeutics ( RKVTF ) , which is advancing new anti-cancer therapeutics based on DNA-damage response technologies, on Friday announced the presentation of its research on novel small-molecule bifunctional inhibitors of PARP1/2 and HDAC enzymes at a symposium in Barcelona, Spain. The company's class of compounds, known as the kt-3000 series, has demonstrated...

Territorial Bancorp Gets Glass Lewis Support for Merger With Hope Bancorp

Oct 26, 2024

08:06 AM EDT, 10/25/2024 (MT Newswires) -- Territorial Bancorp ( TBNK ) said Friday that proxy advisory firm Glass Lewis has joined Institutional Shareholder Services in recommending Territorial shareholders to vote in favor of the company's pending merger with Hope Bancorp ( HOPE ) . The company said its board of directors and management team, which collectively own 9.2% of...